TickerSparkInvestor Intelligence
TickerSparkInvestor Intelligence
Community
Main Feed
Today's Market Intel
Top Stocks
AI-Curated Stock Lists
IPO Calendar
Upcoming Listings
Stock Teasers
The Stock Behind the Promo
Trending Stocks
Today's Big Movers
Earnings Coverage
Flashes & Deep Dives
Macro Updates
Economy & Markets
Stock Reports
AI Research Reports
Commentary
Opinionated Stock Takes
Custom Reports
Stock Deep Dives · Free to Try
AI Analyst
Agentic Chat · Free to Try
Watchlist
Track Your Stocks · Free
Spark Charts
AI Technical Analysis · Free to Try
Intel Dashboard
Daily Trade Ideas
Trade Tracker
AI-Managed Portfolio · Pro
My Portfolio
Brokerage Connected · Pro
Custom Reports
Stock Deep Dives
AI Analyst
Agentic Chat
Watchlist
Your Stocks & Notes
Spark Charts
AI Technical Analysis
Intel Dashboard
Daily Trade Ideas
Trade Tracker
AI-Managed Portfolio
My Portfolio
Brokerage Connected
Account
Plan, Billing & Appearance
Log inCreate Account
← Back to TickerSpark
▌Earnings Flash·November 9, 2026

Hims & Hers Health, Inc. (HIMS) falls on earnings misses

Hims & Hers Health, Inc. (HIMS) falls after reporting earnings misses, sending shares lower as investors react to weaker-than-expected results and outlook concerns.

Earnings FlashHIMSHealthcareMedical - Care Facilities
By TickerSpark·November 9, 2026·2 min read
Hims & Hers Health, Inc. (HIMS) falls on earnings misses
▌Key Takeaway
Hims & Hers Health, Inc. (HIMS) reported a wider-than-expected loss, posting -$0.14 EPS versus estimates for a profit while revenue came in at $0.89B, in line with expectations. Shares fell 13.65% to $22.45 in after-hours trading as investors zeroed in on the company’s inability to convert strong sales growth into earnings power.

Hims & Hers Health, Inc. (HIMS) Falls After Earnings Miss

Hims & Hers Health, Inc. (HIMS) missed on EPS and revenue, posting -$0.14 EPS and $0.89B revenue, while shares fell 13.65% to $22.45 in after-hours trading.

Key Numbers

  • EPS: -$0.14 actual versus $0.05627 estimated, a miss.

§ Product

  • How It Works
  • Custom Reports
  • AI Analyst
  • Intel Dashboard
  • Spark Charts
  • Trade Tracker
  • My Portfolio
  • Plans

§ Research

  • Main Feed
  • Community
  • Stock Reports
  • Macro Updates
  • Blog

§ Company

  • About Us
  • Contact

§ Fine Print

  • Terms of Service
  • Privacy Policy
  • Full Disclaimer
  • Cookie Policy

Notice: All content and data on TickerSpark is for informational purposes only and does not constitute financial or investment advice. All investments involve risk. Please see our Full Disclaimer for more details.

© 2026 Maxwell Cyberlogic LLC

Not Investment Advice

Made in Delaware, USA

Revenue: $0.89B actual versus $0.89B estimated, with the result classified as a miss.
  • After-hours price: $22.45, down 13.65% from the $26.00 regular-session close.
  • Trading volume: 44,878,137 shares versus an average of 10,865,496.
  • Recent EPS trend: -$0.40 on May 11, -$0.37 on Aug. 10, and -$0.14 on Nov. 9, after a $0.07 result on Feb. 23.
  • Profitability Breaks the Growth Narrative

    The main problem sits below the top line. HIMS generated $0.89B in revenue, but EPS came in negative against a positive estimate. That gap suggests sales scale did not translate into the earnings performance investors expected.

    The market reaction was decisive. Shares dropped from $26.00 to $22.45 in after-hours trading, while volume reached 44,878,137 shares. That combination shows investors treated the earnings miss as material rather than routine.

    The latest result also extends three consecutive EPS misses across May, August, and November 2026. On the earnings call, the central issue is the bridge from $0.89B in revenue to -$0.14 EPS, along with the path to ending that miss streak.

    Get AI research on any stock

    Instant reports, daily intelligence, and an AI analyst in your pocket.

    Get Started →

    Bottom Line

    HIMS delivered meaningful revenue but missed on earnings, and the sharp after-hours selloff makes profitability the stock’s immediate test.

    Read the full HIMS research report
    ▌Common Questions

    Frequently asked questions

    +Why did Hims & Hers stock fall after earnings?
    Hims & Hers Health, Inc. (HIMS) fell after reporting -$0.14 EPS versus an estimated $0.05627, even though revenue was $0.89B. The stock dropped 13.65% to $22.45 in after-hours trading because investors focused on the earnings miss and weak profitability.
    +Did Hims & Hers beat revenue in the latest quarter?
    No. Hims & Hers Health, Inc. (HIMS) reported $0.89B in revenue, which matched the estimate but was still classified as a miss in the article. The bigger issue was that EPS came in at -$0.14, well below expectations.
    +What was HIMS earnings per share and how did it compare with estimates?
    Hims & Hers Health, Inc. (HIMS) posted EPS of -$0.14, compared with an estimated $0.05627. That miss reinforced concerns that revenue growth is not yet translating into profitability.
    +How much did Hims & Hers shares move after the earnings report?
    Hims & Hers Health, Inc. (HIMS) fell from a regular-session close of $26.00 to $22.45 in after-hours trading, a drop of 13.65%. Trading volume also surged to 44,878,137 shares versus an average of 10,865,496.
    ▌The Daily Briefing · Free

    A new stock idea, every evening.

    One stock worth watching each weekday, plus the analysis behind it. Free, in your inbox.

    Creates a free TickerSpark account — newsletter included.

    or with email

    Daily market recap + weekly preview. One-click unsubscribe in every email.

    ▌The Full Report

    Want the full picture on HIMS?

    The analyst-grade research report — charts, grades, valuation, and price targets — in 10 minutes.

    Read the HIMS report →Get Full Access →

    Not ready to subscribe? ·

    ▌The Full Report

    Get the full HIMS research report

    • Analyst-grade deep dive
    • Charts, valuation, grades
    • Buy/sell price targets
    Read the HIMS report →
    ▌For Active Investors

    Smarter research, on every ticker

    • Daily market intelligence
    • On-demand stock analysis
    • AI analyst chat
    Get Full Access →

    Cancel anytime

    ▌The Daily Briefing · Free

    A new stock idea, every evening.

    One stock worth watching each weekday, free in your inbox.

    Creates a free TickerSpark account — newsletter included.

    or with email

    Daily market recap + weekly preview. One-click unsubscribe in every email.

    ▌More on HIMS

    More to read

    All articles
    Hims & Hers Health, Inc. (HIMS) falls on deep earnings miss
    HIMS

    Hims & Hers Health, Inc. (HIMS) falls on deep earnings miss

    Hims & Hers Health, Inc. (HIMS) falls after a Q3 miss that went beyond the headline. This deep-dive examines weaker margins, softer guidance, shifting product mix, and the growth-versus-profit tradeoff behind the stock’s decline.

    Nov 10·6 min
    Hims & Hers Health (HIMS): Growth Is Real, But Execution Matters
    HIMS

    Hims & Hers Health (HIMS): Growth Is Real, But Execution Matters

    Hims & Hers is scaling fast, with Q2 revenue up 38% and subscribers up 19%, but profitability, leverage, and regulatory risk keep the story from being a simple growth call. The stock still earns a Buy, though investors need to watch cash flow and margin pressure closely.

    Nov 9·20 min